The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Many teams are approaching agentic AI with a mixture of interest and unease. Senior leaders see clear potential for efficiency and scale. Builders see an opportunity to remove friction from repetitive ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

Israel’s strong presence at the Singapore Airshow highlights a shift toward Asian defense markets as demand for battle‑tested ...

Cincinnati Reds catcher Tyler Stephenson won his arbitration case, earning a $6.8 million salary for the 2026 season. In case ...

At the end of 2024, no AI had even managed to place 100th in one of the major competitions. But they have since vaulted up ...

Microsoft was caught in a software sector sell-off that has left shares trading at a reasonable valuation. Learn why MSFT ...

Like it or not, the justices are about to see AI versions of themselves, speaking words that they spoke in court but that ...